Oppenheimer & Co’s Orthofix Medical OFIX Stock Holding History

Oppenheimer & Co’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,200	Closed	-$147K	–	1713
2025 Q2	$147K	Buy	+13,200	New	+$164K	﹤0.01%	1538

Other funds holding OFIX

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer & Co's OFIX Position: Q3 2025 in Review

Oppenheimer & Co sold out of Orthofix Medical (OFIX) in Q3 2025, closing a stake of 13,200 shares — an estimated $147K sold.

Oppenheimer & Co first reported a position in OFIX in Q2 2025 and held it in 1 quarter. The position peaked at $147K in Q2 2025. 145 funds tracked by Wall St. Rank hold OFIX as of Q3 2025.

Oppenheimer & Co reported no remaining Orthofix Medical position as of Q3 2025 after selling out during the quarter.
Oppenheimer & Co sold 13,200 Orthofix Medical shares in Q3 2025, an estimated $147K.
Oppenheimer & Co first reported a position in Orthofix Medical in Q2 2025 and held it in 1 quarter.
Oppenheimer & Co's Orthofix Medical position peaked at $147K in Q2 2025.
145 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.